The American Journal of Surgery
Volume 194, Issue 2 , Pages 189-191 , August 2007

Perioperative β-blocker therapy and heart rate control during noncardiac surgery

Presented at the 30th Annual Meeting of the Association of VA Surgeons, Cincinnati, OH, May 9–11, 2006

Received 2 June 2006 ,Revised 30 August 2006

References 

  1. Kozak LJ, Owings MF, Hall MJ. National hospital discharge survey: 2002 annual summary with detailed diagnosis and procedure data. Vital Health Stat 13. 2005;158:1–199
  2. Khuri SF, Daley J, Henderson W, et al. The Department of Veterans Affairs’ NSQIP: the first national, validated, outcomes based, risk-adjusted, and peer-controlled program for the measurement and enhancement of the quality of surgical care. Ann Surg. 1998;228:491–507
  3. Mangano DT, Layug EL, Wallace A, et al. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. N Engl J Med. 1996;335:1713–1720
  4. Ashton CM, Petersen NJ, Wray NP, et al. The incidence of perioperative myocardial infarction in men undergoing noncardiac surgery. Ann Intern Med. 1993;118:504–510
  5. Gilbert K, Laroque BJ, Patrick LT. Prospective evaluation of cardiac risk indices for patients undergoing noncardiac surgery. Ann Intern Med. 2000;133:356–359
  6. Auerbach AD, Goldman L. Beta-blockers and reduction of cardiac events in noncardiac surgery: clinical applications. JAMA. 2002;287:1445–1447
  7. Fleisher LA. Preoperative cardiac evaluation. Anesthesiol Clin North Am. 2004;22:59–75
  8. Selzman CH, Miller SA, Zimmerman MA, et al. The case for beta-adrenergic blockade as prophylaxis against perioperative cardiovascular morbidity and mortality. Arch Surg. 2001;136:286–290
  9. Grayburn PA, Hillis LD. Cardiac events in patients undergoing noncardiac surgery: shifting the paradigm from noninvasive risk stratification to therapy. Ann Intern Med. 2003;138:506–511
  10. Shojania KG, Duncan BW, McDonald KM, et al. Safe but sound: patient safety meets evidence-based medicine. JAMA. 2002;288:508–513
  11. Poldermans D, Boersma E, Jeroen JB, et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. N Engl J Med. 1999;341:1789–1794
  12. McGory ML, Maggard MA, Ko CY. A meta-analysis of perioperative beta blockade: what is the actual risk reduction?. Surgery. 2005;138:171–179
  13. Lindenauer PK, Pekow P, Wang K, et al. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med. 2005;353:349–361

PII: S0002-9610(07)00301-7

doi: 10.1016/j.amjsurg.2006.08.090

The American Journal of Surgery
Volume 194, Issue 2 , Pages 189-191 , August 2007

Article Tools

* Image Usage & Resolution